Education
About Us
Working with TipRanks
Follow Us
Zhongzhi Pharmaceutical Holdings Limited (HK:3737)
:3737
RESEARCH TOOLSreports
Total Valuation
Zhongzhi Pharmaceutical Holdings Limited has a market cap or net worth of HK$719.95M. The enterprise value is ―.
Market CapHK$719.95M
Enterprise Value―
Share Statistics
Zhongzhi Pharmaceutical Holdings Limited has 863,600,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding863,600,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Zhongzhi Pharmaceutical Holdings Limited’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 6.70%.
Return on Equity (ROE)0.09
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)6.70%
Return on Capital Employed (ROCE)0.11
Revenue Per Employee859.44K
Profits Per Employee57.00K
Employee Count2,577
Asset Turnover1.11
Inventory Turnover2.68
Valuation Ratios
The current PE Ratio of Zhongzhi Pharmaceutical Holdings Limited is 8.26. Zhongzhi Pharmaceutical Holdings Limited’s PEG ratio is -0.53.
PE Ratio8.26
PS Ratio0.00
PB Ratio0.69
Price to Fair Value0.70
Price to FCF69.49
Price to Operating Cash Flow7.18
PEG Ratio-0.53
Income Statement
In the last 12 months, Zhongzhi Pharmaceutical Holdings Limited had revenue of 2.21B and earned 95.21M in profits. Earnings per share was 0.11.
Revenue2.21B
Gross Profit1.29B
Operating Income136.91M
Pretax Income146.90M
Net Income95.21M
EBITDA170.39M
Earnings Per Share (EPS)0.11
Cash Flow
In the last 12 months, operating cash flow was 107.41M and capital expenditures -96.68M, giving a free cash flow of 10.73M billion.
Operating Cash Flow107.41M
Free Cash Flow10.73M
Free Cash Flow per Share0.01
Dividends & Yields
Zhongzhi Pharmaceutical Holdings Limited pays an annual dividend of HK$0.05, resulting in a dividend yield of 10%
Dividend Per ShareHK$0.05
Dividend Yield10%
Payout Ratio23.77%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.19
52-Week Price Change-6.52%
50-Day Moving Average0.86
200-Day Moving Average0.89
Relative Strength Index (RSI)47.56
Average Volume (3m)250.73K
Important Dates
Zhongzhi Pharmaceutical Holdings Limited upcoming earnings date is Aug 21, 2025, TBA Not Confirmed.
Last Earnings DateMar 26, 2025
Next Earnings DateAug 21, 2025
Ex-Dividend DateMay 23, 2025
Financial Position
Zhongzhi Pharmaceutical Holdings Limited as a current ratio of 1.39, with Debt / Equity ratio of 16.89%
Current Ratio1.39
Quick Ratio0.91
Debt to Market Cap0.11
Net Debt to EBITDA0.13
Interest Coverage Ratio19.58
Taxes
In the past 12 months, Zhongzhi Pharmaceutical Holdings Limited has paid 50.75M in taxes.
Income Tax50.75M
Effective Tax Rate0.35
Enterprise Valuation
Zhongzhi Pharmaceutical Holdings Limited EV to EBITDA ratio is 4.74, with an EV/FCF ratio of 20.38.
EV to Sales0.36
EV to EBITDA4.74
EV to Free Cash Flow20.38
EV to Operating Cash Flow4.45
Balance Sheet
Zhongzhi Pharmaceutical Holdings Limited has HK$167.10M in cash and marketable securities with ¥188.60M in debt, giving a net cash position of HK$21.50M billion.
Cash & Marketable SecuritiesHK$167.10M
Total Debt¥188.60M
Net CashHK$21.50M
Net Cash Per ShareHK$0.02
Tangible Book Value Per ShareHK$1.31
Margins
Gross margin is 58.17%, with operating margin of 6.18%, and net profit margin of 4.30%.
Gross Margin58.17%
Operating Margin6.18%
Pretax Margin6.63%
Net Profit Margin4.30%
EBITDA Margin7.69%
EBIT Margin5.39%
Analyst Forecast
The average price target for Zhongzhi Pharmaceutical Holdings Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast5.79%
EPS Growth Forecast-43.49%